Brachytherapy

1873-14491822019Mar-AprBrachytherapyBrachytherapyUse of interstitial brachytherapy in pelvic recurrence of cervical carcinoma: Clinical response, survival, and toxicity.146153146-15310.1016/j.brachy.2018.11.002S1538-4721(18)30550-6The purpose of this study was to evaluate clinical response, postrecurrence survival, disease-free survival (DFS), and toxicity related to reirradiation in pelvic recurrence of cervical carcinoma.A retrospective cohort study of 45 women undergoing high-dose-rate interstitial brachytherapy (HDR-IB) was conducted from 1998 to 2014. Clinical information, as well as data on the malignancy, primary treatment, HDR-IB technique, and toxicity, was collected. Statistical analysis used chi-square or Fisher's exact test, Kaplan-Meier survival curves and log-rank test, and Cox regression, with p < 0.05 for significance.There were 30 cases (67%) of complete clinical response, with a followup period of 9-129 months (20 alive, 10 died). The 5-year postrecurrence survival rate was 52%. Among 15 women without complete clinical response, the survival rate was low (<8 months). In the 30 women with complete clinical response, the 5-year DFS was 42%. All analyzed variables were not associated with survival. Ultrasonography-based needle placement was not associated with disease control or toxicity. Toxicity was reported in 23 women (51%) with 14 fistulas, unrelated to clinical response. However, there was a higher occurrence of fistula when chemotherapy was used.Reirradiation using HDR-IB for pelvic recurrence of cervical carcinoma yielded a good complete clinical response rate. Postrecurrence survival and DFS rates were higher than expected, equivalent to salvage surgery, but with significant toxicity. Despite toxicity, this technique can be an alternative for selected cases.Copyright © 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.da SilvaVinicius Toloti MoschiniVTMDepartment of Obstetrics and Gynecology, University of Campinas (Unicamp), Campinas, Sao Paulo, Brazil.Fortuna DinizAna PaulaAPService of Radiotherapy, Women's Health Hospital, Campinas, Sao Paulo, Brazil.MartinsJumaraJService of Radiotherapy, Women's Health Hospital, Campinas, Sao Paulo, Brazil.CursinoKleberKService of Ultrasound, Women's Health Hospital, Campinas, Sao Paulo, Brazil.EstevesSergio Carlos BarrosSCBService of Radiotherapy, Women's Health Hospital, Campinas, Sao Paulo, Brazil.TeixeiraJulio CesarJCDepartment of Obstetrics and Gynecology, University of Campinas (Unicamp), Campinas, Sao Paulo, Brazil. Electronic address: juliotex@fcm.unicamp.br.engJournal Article20181224

Publications by authors named "Vinicius Toloti Moschini da Silva"

Use of interstitial brachytherapy in pelvic recurrence of cervical carcinoma: Clinical response, survival, and toxicity.